Literature DB >> 3800800

Pathogenesis of caseous lymphadenitis in sheep and goats.

R G Batey.   

Abstract

The progress of caseous lymphadenitis in sheep and goats is described as involving primary wound infection, lymphatic and haematogenous dissemination, and secondary infection of lymph nodes and various visceral organs. This is followed by elimination or containment of infection, the latter being represented by the characteristic caseous lesions. Resistance to infection is complex involving components of both the specific and non-specific host response. The role of these in pathogenesis is discussed. Bacterial factors including the phospholipase exotoxin and cytotoxic lipid contribute to pathogenesis at a local level with little likelihood of systemic effect in the natural disease. In a disease such as caseous lymphadenitis, lesion site, size or number do not indicate severity of disease but rather, reflect the ability of the host to mount a cellular response to infection.

Entities:  

Mesh:

Year:  1986        PMID: 3800800     DOI: 10.1111/j.1751-0813.1986.tb08064.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  19 in total

1.  Caseous lymphadenitis in goats: the pathogenesis, incubation period and serological response after experimental infection.

Authors:  J K Kuria; P G Mbuthia; E K Kang'ethe; R G Wahome
Journal:  Vet Res Commun       Date:  2001-02       Impact factor: 2.459

2.  Cloning, nucleotide sequence, and expression in Escherichia coli of the phospholipase D gene from Corynebacterium pseudotuberculosis.

Authors:  A L Hodgson; P Bird; I T Nisbet
Journal:  J Bacteriol       Date:  1990-03       Impact factor: 3.490

3.  Attenuation and vaccine potential of aroQ mutants of Corynebacterium pseudotuberculosis.

Authors:  C P Simmons; A L Hodgson; R A Strugnell
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  A serological investigation of caseous lymphadenitis in four flocks of sheep.

Authors:  Frank E Malone; Seán A Fee; Elbarte M Kamp; David C King; Graham J Baird; Kath M O'Reilly; Fiona Ea Murdock
Journal:  Ir Vet J       Date:  2006-01-01       Impact factor: 2.146

5.  Targeted allele replacement mutagenesis of Corynebacterium pseudotuberculosis.

Authors:  Caray A Walker; Willie Donachie; David G E Smith; Michael C Fontaine
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

6.  Vaccine potential of attenuated mutants of Corynebacterium pseudotuberculosis in sheep.

Authors:  C P Simmons; S J Dunstan; M Tachedjian; J Krywult; A L Hodgson; R A Strugnell
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Rational attenuation of Corynebacterium pseudotuberculosis: potential cheesy gland vaccine and live delivery vehicle.

Authors:  A L Hodgson; J Krywult; L A Corner; J S Rothel; A J Radford
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

8.  Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis.

Authors:  Anna C Jacobs; Indriati Hood; Kelli L Boyd; Patrick D Olson; John M Morrison; Steven Carson; Khalid Sayood; Peter C Iwen; Eric P Skaar; Paul M Dunman
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

9.  Protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant Corynebacterium pseudotuberculosis.

Authors:  A L Hodgson; M Tachedjian; L A Corner; A J Radford
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Corynebacterium pseudotuberculosis infection in goats. VIII. The effect of vaccination against experimental infection.

Authors:  G Holstad; J Teige; H J Larsen
Journal:  Acta Vet Scand       Date:  1989       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.